SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001213900-23-032827
Filing Date
2023-04-26
Accepted
2023-04-26 16:09:12
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-04-26

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT fars0423_protarathera.pdf ARS 485014
  Complete submission text file 0001213900-23-032827.txt   669522
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-36694 | Film No.: 23849791
SIC: 2836 Biological Products, (No Diagnostic Substances)